Detalhe da pesquisa
1.
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program.
Nat Commun;
10(1): 4358, 2019 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554818
2.
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.
J Pathol;
249(4): 411-424, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206668
3.
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
Int J Cancer;
145(12): 3453-3461, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125117
4.
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
J Natl Cancer Inst;
111(3): 301-310, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321406
5.
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
Clin Cancer Res;
25(16): 5082-5093, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224344
6.
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer.
Prostate Cancer Prostatic Dis;
22(2): 292-302, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30367117
7.
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.
Cancer Epidemiol Biomarkers Prev;
27(11): 1376-1383, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108099
8.
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.
Eur Urol;
74(4): 444-452, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853306
9.
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.
Clin Cancer Res;
24(16): 3908-3916, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760221
10.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Gigascience;
7(6)2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757368
11.
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
EBioMedicine;
31: 182-189, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29729848
12.
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.
J Cancer Res Clin Oncol;
144(5): 883-891, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511883
13.
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Eur Urol;
73(4): 524-532, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28330676
14.
Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Eur Urol Focus;
4(4): 540-546, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28753844
15.
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.
Eur Urol;
73(2): 168-175, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28400167
16.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
JCO Precis Oncol;
20182018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761387
17.
Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma.
BMC Cancer;
17(1): 759, 2017 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132337
18.
Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.
Oncotarget;
8(31): 50804-50813, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881605
19.
LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.
Cancer Res;
77(20): 5479-5490, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28916652
20.
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup.
Clin Cancer Res;
23(22): 7072-7083, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899973